PRESS RELEASE
15/12/2021
- 74 Human & Work managers and employees, from all the group's brands, countries and businesses, have decided to become shareholders and to unite their destiny to build, by 2025, the European leader in Human at Work.
- Supported by the group's pool of investors, GENEO Capital Entrepreneur, Bpifrance and NCI, who at the same time renewed their confidence in the future of Human & Work, the managers and employees now control 69.2% of the group's capital.
- On the occasion of this operation, the group, now present in France, Italy and Spain, presents a new business plan for the next four years. Illustrated by the promise "Care for people first", the ambition of this project is to make Human & Work the reference brand in HR consulting in Europe by 2025.
Human & Work's new business plan will enable the group to meet three challenges:
- Strengthen what makes the group's DNA: its unique expertise in the Human at Work field, its scientific basis and the quality of the experience offered to its clients;
- To consolidate its European leadership in psychological health at work, to respond to the growing needs of companies in terms of diversity and inclusion, and to deepen its support for managers in their careers and their mission to transform organisations;
- To become the partner of reference for large European and multinational companies, thanks to the digitalisation of the group's activities, its international development and its ambitious social impact strategy.
David Mahé, President and Founder of Human & Work, comments: "The success of the sequence we have just completed is both a great source of pride and responsibility.We are proud of this success because it illustrates the strong commitment of our teams, who are passionate about their work, to our ambitious entrepreneurial project: that of becoming, beyond the grouping of expert firms, a leading global human resources consulting group, capable of responding to all the issues related to the transformation of work and the place of the human being in the workplace, in France and around the world.
This is a huge responsibility, because more than 1,000 companies and their 8 million employees are counting on us to implement our promise: Care for people first.
I would also like to thank our banking partners and our pool of investors, GENEO, Bpifrance and NCI, for their confidence in us and their decision to continue investing alongside us to support our development.
François Picarle, Associate Director of GENEOadds: "We are proud to accompany Human & Work in its development since 2019. We share strong values, particularly on CSR issues, which correspond to GENEO's raison d'être and are at the heart of our interventions. The Growth Plan that we have defined with Human & Work has enabled the group to make significant progress and to turn a corner, particularly in terms of parity and employee shareholding. We are very proud to see that Human & Work is sharing the fruits of its growth with its teams by integrating them into its development. As investors, we play our role to the full when capital is passed on to those who participate in the company's success on a daily basis. For all these reasons, GENEO is delighted to be at Human & Work's side for the years to come.
Constance Pauliac, BpifranceBpifrance is delighted to continue to support the Human & Work group - renewed since 2016 - in this new key stage in the life of the group. Having already become the European leader, Human & Work still has strong ambitions to grow internationally, and Bpifrance is particularly keen to support this development, which will be based - again and again - on the Human factor."
Anne-Cécile Guitton, NCI Congratulations to David and the Human and Work teams, who work every day for a more peaceful, efficient and equitable world of work. We continue to support this great project with enthusiasm and determination!
Human & Work's advice for this operation
Lawyers Joffe et Associés - Romain Soiron, Aymeric Degremont, Paddy Pascot
M&A advisory Financing : G2 Invest - Guillaume Somekh
Investors Geneo - François Picarle, Louis Charrier ; Bpifrance - Fabrice Lemarchand, Constance Pauliac ; NCI - Anne-Cécile Guitton, Elodie Aymard
Financing Banque Populaire Rives de Paris - Eric Beasse ; Caisse d'Epargne Ile-de-France - Maxime Moysan ; Société Générale - Delphine Kaptan
About Human & Work
Founded in 2016, Human & Work is the first European consulting group dedicated to the Human at work. Through its member firms: Stimulus, dedicated to psychological health at work, Nexmove, a benchmark in career management for executives, and Equilibres, a pioneer in professional inclusion, the group places the human factor at the centre of its support.
Human & Work has 200 employees in France, Italy and Spain who are experts in well-being at work, professional development, equality, ethics and work transformation.
Human & Work deploys its passion and commitment to more than a thousand European companies and their eight million employees to build an inclusive, responsible and serene world of work.
Website : https://humanandwork.com/
Press Contacts Human & Work - Cabinet Enderby
Mathias Carteron - 06 68 27 83 46 - mca@enderby.fr
Marie Grillet - 06 45 42 91 00 - mgr@enderby.fr
About GENEO
GENEO Capital Entrepreneur's raison d'être is to give SMEs and SMIs the means to achieve their ambitions, in a sustainable and positive impact approach.
As an "evergreen" investment company with a 99-year lifespan, GENEO provides tailor-made capital that adapts to the pace of each company and provides responsiveness and flexibility. GENEO's capital is mainly held by families and entrepreneurs who have brought its resources to nearly €300 million. These resources are regularly increased as GENEO and the companies it invests develop.
As a business partner, GENEO works alongside companies to provide support for the implementation of their structuring, growth and transformation projects. The terms of this operational support are adapted to the specific needs of each company and formalised jointly by the GENEO team, the management team and the company's other shareholders in a "Growth Book".
Finally, to give each generation the means to achieve its ambitions, GENEO allocates a significant part of the team's carried interest to an endowment fund that supports job creation in disadvantaged areas and the reintegration of disadvantaged people into employment.
Passionate about those who make, create and want to move the lines, the only ambition of the GENEO team is to bring each entrepreneur's ambition to the highest level.
For more information FOR MORE INFORMATION: www.geneocapitalentrepreneur.com
About Bpifrance
Bpifrance's equity investments are operated by Bpifrance Investissement. Bpifrance finances companies - at every stage of their development - with credit, guarantees and equity. Bpifrance supports them in their innovation and international projects. Bpifrance now also provides their export activity through a wide range of products. Advice, university, networking and acceleration programmes for start-ups, SMEs and ETIs are also part of the offer to entrepreneurs.
More information on www.Bpifrance.fr - https://presse.bpifrance.fr/
About NCI
NCI, a major player in regional private equity, invests skills and equity in business creation, development and transfer projects. With a historical double-digit growth rate and €330 million under management (entrusted by public and private institutional investors, family offices and company directors), NCI reconciles finance and economic development in a high-potential region: Normandy, Hauts-de-France, Brittany, Pays de la Loire and Ile de France.
Website https://www.n-ci.com/[/vc_column_text]
